Skip to content
zameds

Lacosamide (Lacopat, Vimcosa)

Lacosamide

Macleods Pharmaceuticals SA (Pty) Ltd

S3

Registration

Applicant
Macleods Pharmaceuticals SA (Pty) Ltd
Registrations
7
Schedule source
Consolidated Schedules 06 July 2026

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Lacopat 50

EACH LOZENGE CONTAINS LACOSAMIDE 50,0 mg

5057071357/2.5/0713RegisteredS3None
Lacopat 100

EACH TABLET CONTAINS LACOSAMIDE 100,0 mg

10057071457/2.5/0714RegisteredS3None
Lacopat 150

EACH TABLET CONTAINS LACOSAMIDE 150,00 mg

15057071557/2.5/0715RegisteredS3None
Lacopat 200

EACH TABLET CONTAINS LACOSAMIDE 200,0 mg

20057071657/2.5/0716RegisteredS3None
Vimcosa 50

EACH TABLET CONTAINS LACOSAMIDE 50,0 mg

50570717.71357/2.5/0717.713RegisteredS3None
Vimcosa 150

EACH TABLET CONTAINS LACOSAMIDE 150,00 mg

150570719.71557/2.5/0719.715RegisteredS3None
Vimcosa 200

EACH TABLET CONTAINS LACOSAMIDE 200,0 mg

200570720.71657/2.5/0720.716RegisteredS3None

Regulatory status

Where S3 sits on the scale

Needs a doctor's prescription, dispensed by a pharmacist.

Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S3, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Lacosamide

  • S3: Lacosamide

    Consolidated Schedules 06 July 2026, line 3864

Pharmacological class: Anticonvulsants, including anti-epileptics. (class 2.5)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C13H18N2O3250.29 g/mol

(2R)-2-Acetamido-N-benzyl-3-methoxypropanamide

Drag to rotate. Structure from PubChem CID 219078.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles